Senti Biosciences secures $53m funding to advance therapeutic design platform

This article was originally published here

Senti Biosciences has completed a $53m round of funding to support the expansion of their therapeutic design platform.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply